Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in COGT — Cogent Biosciences, Inc.

CIK 923093 STAMFORD, CT

Position in COGT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$5,681,139 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
10 quarters on record

Common Shares in COGT Over Time

Shares Held

Position Value (USD)

Derivatives in COGT

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$1,046,928
PutShares
27,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in COGT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,046,928 27,200
2025-12-31 $5,681,139 159,942
2025-03-31 $255,904 42,722
2024-12-31 $131,188 16,819
2024-06-30 $358,544 42,532
2023-12-31 $341,222 58,031
2023-09-30 $457,967 46,971
2023-06-30 $194,507 16,428
2023-03-31 $432,387 40,073
2022-12-31 $400,045 34,606